Quipt Home Medical Corp (QIPT) FinancialsQIPTQuipt Home Medical Corp

Evaluating the bottom line, Quipt Home Medical Corp maintains a gross margin of 56.38%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 1.54%, while the net margin is -0.88%. These profitability ratios, combined with a Return on Equity (ROE) of -10.30%, provide a clear picture of how effectively QIPT converts its operational activities into shareholder value.

In the context of the broader market, QIPT competes directly with industry leaders such as NRC and ASTH. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, QIPT's gross margin of 56.38% stands against NRC's 56.41% and ASTH's 9.10%. Such benchmarking helps identify whether Quipt Home Medical Corp is trading at a premium or discount relative to its financial performance.

In Q1 2026, revenue increased by 31.96% YoY to $80.996M, but net income dropped by 2.86% YoY to -$1.053M, and EPS decreased by 33.33% YoY to -0.02. Gross margin improved to 56.38%, up 6.10% YoY.